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A B S T R A C T
Bardet-Biedl syndrome (BBS) is genetically heterogeneous with at least 21 genes involved, and BBS10 encodes, together with BBS6 and BBS12, chaperonin-like
proteins which are important for the assembly of the multiprotein complex, the BBSome encoded by other BBS genes. Here we describe the successful generation of
an induced pluripotent stem cell (iPSC) line KCi002-A from a male with BBS, homozygous for the disease causing variant c.271insT, p.(Cys91fsX95) in BBS10.
Resource table
Unique stem cell line identifier KCi002-A
Alternative name(s) of stem cell line BBS10 Clone1A
Institution Rigshospitalet, Kennedy Center
Contact information of distributor Lisbeth Birk Møller, Lisbeth.Birk.Moeller@regionh.dk
Type of cell line induced pluripotent stem cell (iPSC)
Origin Human
Additional origin info Male, Caucasian
Cell source Dermal fibroblasts
Clonality Clonal
Method of reprogramming Nucleofection with non-integrating episomal plasmids carrying
OCT3/4, SOX2, KLF4, L-MYC, LIN28 and shP53
Genetic modification NA
Type of modification NA
Associated disease Autosomal recessive Bardet-Biedl syndrome
Gene/locus BBS10, Chr 12: g.7674149insT, p.(Cys91fsX95), homozygous.
Ref sequence: NM_024685.3
Method of modification NA
Name of transgene or resistance NA
Inducible/constitutive system NA
Date archived/stock date 25-01-2018
Cell line repository/bank NA
Ethical approval The study was approved by the regional scientific ethical committee
in the Capital Region of Denmark (H-3-2014-140). Written informed
consent was obtained from the patients.
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Resource utility
BBS is a ciliopathy and a chaperonopathy. BBS10 encodes a cha-
peronin-like protein, which participates in the assembly of the BBSome.
The generated iPSC line represents a useful source to investigate the
effect of the chaperonin complex on the pathophysiology of BBS, in-
cluding assembly of the BBSome, in different tissues.
Resource details
Bardet-Biedl syndrome (BBS) is a rare autosomal recessive disorder
having an estimated prevalence in Denmark of 1/59.000 (Hjortshøj
et al. 2010). BBS is a ciliopathy, defined as diseases caused by defects in
ciliary structure and/or function. Today 21 different genes involved in
BBS are known. Because three genes BBS6, BBS10 and BBS12 encode
chaperonin-like proteins, BBS is now also considered to belong to the
group of diseases termed chaperonopathies (Seo et al. 2010; Stoetzel
et al. 2006). The chaperonin-like proteins form the chaperonin-complex
which localize to the ciliary basal body and centrosomes. The complex
is important for assembly of another BBS protein complex called the
BBSome. It has been shown that disease causing variants in BBS6,
BBS10 and BBS12 result in a malfunctioning BBSome (Zhang et al.
2012). To investigate the role of BBS10 in ciliary function, an iPSC line
from a patient homozygous for the pathogenic variant c.271insT,
p.Cys91fsX95 in the BBS10 gene was created.
Patient specific human dermal fibroblasts from a male homozygous
for the variant c.271insT, p.(Cys91fsX95), in BBS10, were repro-
grammed to iPSC by nucleofection of three episomal plasmids expres-
sing the human genes OCT3/4, SOX2, KLF4, L-MYC, LIN 28 and a short
hairpin RNA against P53 (shP53). Sequencing of the generated iPSC line
KCi002-A, confirmed the presence of the variant (Fig. 1A). Investigation
for the episomal plasmids in genomic DNA from KCi002-A by quanti-
tative PCR (Applied Biosystems 7500 Fast system), using plasmid spe-
cific primers for OCT3/4, SOX-2, KLF4, LIN28 and L-MYC (Table 2),
using SYBR green, confirmed that none of the three episomal plasmids
were integrated into the genome (Fig. 1B). DNA from control fibroblast
72 h post transfection and DNA from un-transfected fibroblasts were
used as a positive and negative control (Fig. 1B). Primers for the cor-
responding endogenous genes were included as controls (not shown).
Investigation of the generated iPSC demonstrated a normal karyotype
(46,XY) (Fig. 1C). Short tandem repeat (STR)-PCR profile analysis,
where 22 different loci were analysed, showed 100% identity match
between the parental fibroblast cell line and KCi002-A (submitted in
archive with journal). The pluripotency status of KCi002-A was verified
by RT-qPCR increased expression of OCT4, NANOG, SOX2, TDGF1,
DNMT3B, GARB3 and GDF3 (Fig. 1D) using Taq-man probes (Table 2).
The mRNA level of the different genes, were normalized to GAPDH
mRNA. RNA from untreated fibroblasts and from a control iPSC line
was included as a negative and positive control. These results were
further underlined by immunochemical demonstration of Oct 3/4 and
Nanog proteins in the nucleus, and presence of the pluripotency surface
markers recognized by TRA-1-60, TRA-1-81 and SSEA3 antibodies in
the cytoplasm (Fig. 1E). The differentiation potential of the generated
iPSC line was investigated by spontaneous differentiation. Im-
munochemical examination after three weeks of differentiation de-
monstrated expression of the mesodermal marker, α-smooth-muscle
actin (SMA), the endodermal marker, α-feto protein (AFP) and the ec-
todermal marker, β-III-tubulin (β-tub) (Fig. 1F). All together these data
show that we have successfully created an iPSC line, KCi002-A
(Table 1).
Materials and methods
Reprogramming
Fibroblast were cultivated in DMEM-F12 with GlutaMAX, 10%
foetal bovine serum, 1% penicillin-streptomycin, (all from Gibco), in a
37 °C humidified 5%-CO2 incubator. Amaxa Nucleofector™ 2b/program
V-024 was used for the transfection in the Primary Mammalian
Fibroblasts buffer (Lonza) with 1,25 ng of each of the reprogramming
plasmids; hOct3/4, hSK, hUL (Addgene #27077, #27078, #27080) for
5×105 cells. Transfected cells were seeded on gelatine (Sigma) coated
dishes without antibiotics for 24 h followed by cultivation using stan-
dard fibroblast conditions. Day 6 post transfection cells were trans-
ferred to Corning ESC grade Matrigel coated dishes in mTeSR1 medium
(stem cell) in 5% CO2, 5% O2 and 90% N2. The iPSC colonies were
harvested from day 20. The iPSC were split using 0,5mM ultrapure
EDTA (Gibco) at around 70% confluency and cryopreserved in mTeSR1
supplemented with 10% DMSO.
Karyotyping
iPSC were incubated for 45min with KaryoMAX colcemid, dis-
sociated with 0,5mM ultrapure EDTA (Gibco), treated with hypotonic
solution, and then fixed with fresh 75% methanol and 25% acetic acid.
The karyotyping was performed on metaphase chromosomes using
Giemsa staining.
Genomic DNA isolation, Integration, Genotyping and Short tandem Repeat
(STR) analyses
DNA was purified using DNeasy Blood and Tissue kit (QIAGEN).
Integration analysis was performed by Quantitative PCR using plasmid
specific primers in combination with SYBR green (Table 2). Data were
analysed using the ΔΔCT method and the amounts were normalized to
GAPDH. To confirm the identity of the cell-line, genotyping and STR
analysis were performed using BBS10 specific primers and Elucigene
QST*R PLUSv2 respectively.
Quantitative real time reverse transcriptase polymerase chain reaction (RT-
qPCR)
RNA purified by RNeasy kit (Qiagen) was DNase treated (DNase
I,Invitrogen) followed by cDNA synthesis (High Capacity cDNA
kit,Applied Biosystems). Taqman probes were used (Table 2). Data was
analysed using relative standard curve method. Expression level was
normalization to GAPDH.
In vitro differentiation
iPSC were dissociated to small aggregates using 0,5mM ultrapure
EDTA (Gibco) and seeded in ultra-low adhesion plates (CORNING) in
mTeSR1 supplemented with ROCK inhibitor to induce embryoid body
formation. Day two after seeding, media was changed to DMEM-
F12+GlutaMAX (Gibco) supplemented with 20% knock-out serum
replacement (Gibco), 1× non-essential amino acids (Sigma), 0,1mM 2-
Fig. 1. Characterization of BBS10 Clone 1A line (KCi002-A). A. WT sequences and mutation in KCi002-A in the same regions of the BBS10 gene. B. Quantitative real
time PCR showing absence of episomal plasmids in BBS10 Clone 1A (KCi002-A) and control fibroblasts and presence of plasmids in transfected fibroblasts. C.
Karyotype of representative metaphase showing normal 46 chromosomes (XY). D. mRNA expression of pluripotency markers in control iPSC line and in BBS10 Clone
1A (KCi002-A). E. Confocal images showing immunodetection of pluripotency-associated markers in BBS10 Clone 10 (KCi002-A). F. Immunofluorescence analysis of
in vitro differentiation of BBS10 Clone 1A (KCi002-A) EBs using specific antibodies against the mesodermal marker α-smooth muscle actin (SMA), endodermal marker
α-fetoprotein (AFP) and the ectodermal marker βIII-tubulin (βtub). Nuclei were stained with DAPI. Scale bar 50 μM.
C.A.B. Hey et al. Stem Cell Research 33 (2018) 46–50
48
Table 1
Characterization and validation.
Classification Test Result Data
Morphology Photography Normal Not shown
Phenotype Immunocytochemistry Positive for Oct3/4, Nanog, SSEA3, Tra-1-60, Tra-1-81 Fig. 1 panel E
RT-qPCR (TaqMan probes; Applied Biosystems
7500 Fast system)
Positive expression of OCT4, NANOG, SOX2, TDGF1, DNMT3B,
GARB3 and GDF3
Fig. 1 panel D
Genotype Karyotype (G-banding) and resolution 46,XY, resolution 450–500 Fig. 1 panel C
Identity Microsatellite PCR (mPCR) NA NA
STR analysis Elucigene QST*R PLUSv2 22 sites were tested. 100% identity match between parental
fibroblasts and KCi002-A
Submitted in archive with
journal
Variant analysis Sanger sequencing GENE: BBS10 Fig. 1 panel A
Homozygous
Chr12: g.7674149insT, p.(Cys91fs*95)
Southern Blot OR WGS NA NA
Microbiology and
virology
Mycoplasma Mycoplasma testing by RT-PCR; Negative Supplementary File 1
Differentiation potential Embryoid body formation Presence of α-smooth muscle actin (SMA), α-fetoprotein (AFP) and
βIII-tubulin (βtub) were used to confirm formation of the three germ
layers.
Fig. 1 panel F
Donor screening HIV 1+2 Hepatitis B, Hepatitis C NA NA
Genotype additional info Blood group genotyping NA NA
HLA tissue typing NA NA
Table 2
Reagents details.
Antibodies used for immunocytochemistry
Antibody Dilution Company Cat # and RRID
Pluripotency marker Rabbit anti-NANOG 1:500 PeproTech Cat# 500-P236, RRID: AB_1268805
Pluripotency marker Mouse anti-OCT3/4 1:200 Santa Cruz Biotechnology Cat# sc5279, RRID: AB_628051
Pluripotency marker Rat anti SSEA3 1:200 BioLegend Cat# 330302, RRID: AB_1236554
Pluripotency marker Mouse anti-TRA-1-60 1:200 BioLegend Cat# 330602, RRID: AB_1186144
Pluripotency marker Mouse anti-TRA-1-81 1:200 BioLegend Cat# 330702, RRID: AB_1089240
Differentiation marker, Mesoderm Mouse anti- α-smooth muscle actin (SMA) 1:500 Dako Cat# M0851, RRID: AB_2223500
Differentiation marker, Endoderm Rabbit anti-α-fetoprotein (AFP) 1:500 Dako Cat# A0008, RRID: AB_2650473
Differentiation marker, Ectoderm Mouse anti-βIII tubulin (βtub) 1:4000 Sigma-Aldrich Cat# T8660, RRID: AB_477590
Secondary antibody Alexa Flour Goat Anti-Rabbit 488 1:800 Life Technologies Cat# A11008, RRID: AB_143165
Secondary antibody Alexa Flour Donkey Anti-Mouse 546 1:800 Life Technologies Cat# A10036, RRID: AB_2534012
Secondary antibody Alexa Flour Rabbit Anti-Rat 488 1:800 Molecular Probes Cat# A-21210, RRID: AB_2535796
Primers
Target Forward/Reverse primer (5′-3′)
Episomal Plasmids (qPCR) OCT3/4 Plasmid (Pla) CATTCAAACTGAGGTAAGGG/TAGCGTAAAAGGAGCAACATAG
Episomal Plasmids (qPCR) OCT3/4 Endogenous (CDS) CCCCAGGGCCCCATTTTGGTACC/ACCTCAGTTTGAATGCATGGGAGAGC
Episomal Plasmids (qPCR) KLF4 Plasmid CCACCTCGCCTTACACATGAAGA/TAGCGTAAAAGGAGCAACATAG
Episomal Plasmids (qPCR) KLF4 Endogenous ACCCATCCTTCCTGCCCGATCAGA/TTGGTAATGGAGCGGCGGGACTTG
Episomal Plasmids (qPCR) SOX2 Plasmid TTCACATGTCCCAGCACTACCAGA/TTTGTTTGACAGGAGCGACAAT
Episomal Plasmids (qPCR) SOX2 Endogenous TTCACATGTCCCAGCACTACCAGA/TCACATGTGTGAGAGGGGCAGTGTGC
Episomal Plasmids (qPCR) L-MYC Plasmid GGCTGAGAAGAGGATGGCTAC/TTTGTTTGACAGGAGCGACAAT
Episomal Plasmids (qPCR) L-MYC Endogenous GCGAACCCAAGACCCAGGCCTGCTCC/CAGGGGGTCTGCTCGCACCGTGATG
Episomal Plasmids (qPCR) LIN28 Plasmid AGCCATATGGTAGCCTCATGTCCGC/TAGCGTAAAAGGAGCAACATAG
Episomal Plasmids (qPCR) LIN28 Endogenous AGCCATATGGTAGCCTCATGTCCGC/TCAATTCTGTGCCTCCGGGAGCAGGGTAGG
House-Keeping Gene (qPCR) GAPDH (1) ACCACAGTCCATGCCATCAC/TCCACCACCCTGTTGCTGTA
Patient variant (Seq.) BBS10 ex 2 AGCCAGCCTTCTGAAAATGA/TTCTTCCCACTCTTCCACAAA
Taqman probes
Target Assay Id
Pluripotency marker (RT-qPCR) POU5F1/OCT4 Thermo Fisher Scientific Hs04260367_g1
Pluripotency marker (RT-qPCR) NANOG Thermo Fisher Scientific Hs04260366_g1
Pluripotency marker (RT-qPCR) SOX2 Thermo Fisher Scientific Hs01053049_s1
Pluripotency marker (RT-qPCR) TDGF1 Thermo Fisher Scientific Hs02339497_g1
Pluripotency marker (RT-qPCR) DNMT3B Thermo Fisher Scientific Hs00171876_m1
Pluripotency marker (RT-qPCR) GARB3 Thermo Fisher Scientific Hs00241459_m1
Pluripotency marker (RT-qPCR) GDF3 Thermo Fisher Scientific Hs00220998_m1
House-Keeping Gene (RT-qPCR) GAPDH Thermo Fisher Scientific Hs99999905_m1
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mecaptoethanol (Sigma) and 1% pen/strep (Gibco). After 1 week of
suspension culture the aggregates were transferred to adherent culture
in DMEM F-12 with GlutaMAX, 10% FBS and 1% pen/strep media on
gelatine (Sigma,) coated coverslips. Changes in morphology were fol-
lowed for two weeks, after which the cells were fixed and investigated
by immunocytochemistry.
Immunocytochemistry
The iPSC grown on gelatine or matrigel (for pluripotency) coated
coverslips were fixed using 4% paraformaldehyde (Hounisen) for
15min, permeabilized using 0,2% TritonX-100 in PBS for 15min.
Followed by incubation in blocking buffer (3% BSA, 0,2% TritonX-100
in PBS) for 1 h. Incubation with primary antibodies was performed for
2 h, followed by incubation with secondary antibodies for 45min, all
diluted in blocking buffer at RT – Nuclei were visualized using DAPI.
Antibodies are specified in Table 2.
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